Related Experiment Video
Updated: Aug 4, 2026

06:48
Clinical Anthropometrics and Body Composition from 3-Dimensional Optical Imaging
Published on: June 7, 2024
Rationale for physicians' decisions to refer obese patients
Summary
Physician referral decisions for patients with obesity to endocrinologists are primarily driven by patient preference, not clinical suspicion of endocrine disorders. This impacts healthcare costs for obesity management.
Area of Science:
- Internal Medicine
- Endocrinology
- Health Services Research
Background:
- Rising healthcare costs in American society are a significant concern.
- Referrals to specialists, such as endocrinologists, add to overall patient costs.
- Obesity is a complex chronic condition often requiring behavioral change, with standard therapies yielding suboptimal outcomes.
Purpose of the Study:
- To investigate the primary factors influencing physician decisions to refer patients with uncomplicated obesity to endocrinologists.
- To understand the decision-making process in specialist referrals for obesity management.
Main Methods:
- A study involving 45 physicians across three medical specialties was conducted.
- Physicians evaluated a standardized set of 24 case reports detailing obese women without apparent endocrine disease cues.
- Referral decision-making was analyzed based on these simulated patient encounters.
Main Results:
- The patient's expressed desire to consult an endocrinologist was the predominant factor in referral decisions.
- Referrals were not significantly influenced by the physician's suspicion of an underlying endocrine disorder.
- Concerns about increased patient morbidity or the need to rule out endocrine disease were not primary drivers for referral.
Conclusions:
- Physician referral patterns for uncomplicated obesity to endocrinology are largely patient-driven.
- The current referral process may not align with clinical indications for endocrine evaluation, potentially increasing healthcare expenditures.
- Further research is needed to optimize referral strategies for cost-effective obesity care.
Related Concept Videos
Methods of Documentation VI: Case Management Model
The case management model is a multidisciplinary approach that involves healthcare professionals from diverse disciplines, such as physicians, nurses, therapists, social workers, and pharmacists, working collaboratively to address the various needs of patients. Each healthcare professional brings unique expertise and perspectives, contributing to a more comprehensive understanding of the patient's condition and tailoring treatment plans accordingly.
For example, a patient with a chronic illness...
For example, a patient with a chronic illness...
Obesity
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Drug Dosing: Obese Patients
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...

